Tri-Cyclen Lo Clears FDA; Ortho-McNeil Patches Up Contraceptive Line
Executive Summary
Ortho-McNeil is ready to launch the second pillar in its contraceptive product line defense following the approval of Tri-Cyclen Lo (norgestimate/ethinyl estradiol) Aug. 22
You may also be interested in...
Ortho Oral Contraceptives May Add Folic Acid, New Patent Life
Johnson & Johnson is pursuing a novel strategy to revive its oral contraceptive line: development of a patent-protected combination with folic acid
Ortho Oral Contraceptives May Add Folic Acid, New Patent Life
Johnson & Johnson is pursuing a novel strategy to revive its oral contraceptive line: development of a patent-protected combination with folic acid
Watson “Authorized” Generic Tri-Cyclen Will Share Market With Barr
Watson will launch an "authorized" generic version of Ortho-McNeil'soral contraceptive Ortho Tri-Cyclen when Barr enters the market with its generic under an agreement between Watson and Ortho announced Oct. 28